Effects of ABT-089 on Smoking Abstinence Symptoms and Reward

NCT01756053 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped Trial discontinued based on the results of an interim futility analysis.

Conditions

Nicotine Addiction

Interventions

DRUG: ABT-089
DRUG: Placebo

Sponsor

University of Pennsylvania